Jazz Pharmaceuticals
JAZZ
#2139
Rank
$6.82 B
Marketcap
$109.40
Share price
1.83%
Change (1 day)
-22.51%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$1.41

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.41. In 2022 the company made an earnings per share (EPS) of -$3.54 an increase over its 2021 EPS that were of -$5.38.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.41-60.17%
2022-$3.54-34.2%
2021-$5.38-224.83%
2020$4.31-53.25%
2019$9.2223.59%
2018$7.46-8.24%
2017$8.1323.74%
2016$6.5722.12%
2015$5.38478.49%
2014$0.93-74.93%
2013$3.71-27.11%
2012$5.0969.1%
2011$3.01245.98%
2010$0.87-462.5%
2009-$0.24-96.7%
2008-$7.28-27.04%
2007-$9.9865.47%
2006-$6.03-4.59%
2005-$6.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.74-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$8.29-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.02 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$2.00 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel